| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP &Chief Accounting Officer | SVP &Controller
1 company
Silva Paul M is a SVP &Chief Accounting Officer at VERTEX PHARMACEUTICALS INC / MA. Recent SEC Form 4 filings include 0 buys and 46 sells.
Estimated insider holdings value: $4.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2021 | VRTX Vertex Pharmaceuticals Inc / Ma | SVP &Chief Accounting Officer | Sell | 2,782 | $211.45 | $588,255.25 | -6.1% | -0.3% | +9.7% | |
| Feb 25, 2021 | VRTX Vertex Pharmaceuticals Inc / Ma | SVP &Chief Accounting Officer | Sell | 1,080 | $213.47 | $230,551.50 | -1.7% | -2.9% | +8.1% | |
| Feb 18, 2021 | VRTX Vertex Pharmaceuticals Inc / Ma | SVP &Chief Accounting Officer | Sell | 4,295 | $211.83 | $909,827.62 | -7.2% | +2.0% | +9.4% | |
| Feb 11, 2021 | VRTX Vertex Pharmaceuticals Inc / Ma | SVP &Chief Accounting Officer | Sell | 1,498 | $210.57 | $315,436.80 | -3.0% | +1.0% | +11.1% | |
| Aug 6, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | SVP &Controller | Sale+OE | 1,078 | $271.17 | $292,318.85 | -1.7% | - | - | |
| Aug 3, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | SVP &Controller | Sale+OE | 809 | $278.30 | $225,141.57 | -1.3% | - | - | |
| Jul 13, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | SVP &Controller | Sale+OE | 860 | $292.03 | $251,144.60 | -0.8% | - | - | |
| May 15, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | SVP &Controller | Sell | 151 | $284.00 | $42,884.58 | -0.1% | - | - | |
| May 6, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | SVP &Controller | Sale+OE | 1,076 | $272.74 | $293,471.78 | -1.2% | - | - | |
| May 4, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | SVP &Controller | Sale+OE | 809 | $260.87 | $211,047.75 | -1.1% | - | - |